Wasserlauf Jeremiah, Passman Rod S
Division of Cardiology, Northwestern University Feinberg School of Medicine, 646 North St. Clair, Suite 600, Chicago, IL 60611, USA.
Division of Cardiology, Northwestern University Feinberg School of Medicine, 251 East Huron Street, Suite 8-503, Chicago, IL 60611, USA.
Card Electrophysiol Clin. 2018 Mar;10(1):75-85. doi: 10.1016/j.ccep.2017.11.007.
Device-detected atrial high-rate episodes (AHREs) are frequently encountered in patients with no history of atrial fibrillation (AF) and represent a challenge for clinicians because patients with device-only documented AF have not been included in clinical trials of anticoagulants and other AF therapies. For patients with known history of AF, wireless continuous rhythm monitoring and rapidly acting oral anticoagulants offer the possibility of tailored anticoagulation in response to AHREs, with studies ongoing to evaluate the safety of this approach. This article provides an overview of current evidence on device-detected AHREs and evolving areas of investigation.
在无房颤（AF）病史的患者中，经常会检测到设备检测到的房性高率发作（AHREs），这对临床医生来说是一项挑战，因为仅通过设备记录房颤的患者未被纳入抗凝剂和其他房颤治疗的临床试验。对于有已知房颤病史的患者，无线连续心律监测和快速起效的口服抗凝剂为根据AHREs进行个性化抗凝提供了可能性，目前正在进行研究以评估这种方法的安全性。本文概述了关于设备检测到的AHREs的当前证据以及不断发展的研究领域。
